🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for NASH

Effectiveness of Bariatric Surgery for NAFLD/NASH NCT04366999n/a1 site📍 Beijing Beijing Friendship Hospital · Tests: SG, RYGB, OAGB Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site📍 Shanghai Ruijin Hospital · Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study NCT05974904n/a1 site📍 Chongqing Chongqing Medical University · Tests: high-sensitivity C-reactive protein to albumin ratio Prospective Cohort Study in Patients With NAFLD NCT00575133n/a1 site📍 Zurich University of Zurich Comorbidities Resolution After MGB Surgery and Change in Body Composition NCT06015620n/a1 site📍 Bhubaneswar All India Institute of Medical Sciences, Bhubaneswar · Tests: Mini gastric bypass surgery Liver Damage and Cardiometabolic Disorders in NAFLD NCT04036357n/a1 site📍 Rome University of Roma La Sapienza Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD NCT07632677n/a22 sites📍 Bengbu📍 Hefei📍 Wuhu The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: iLivTouch (Vibration-controlled transient elastography) Digital Early Warning System for Acute Lung Injury in Liver Surgery NCT07070362n/a4 sites📍 Beijing📍 Beijing📍 Chongqing Beijing Tsinghua Chang Gung Hospital Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease NCT05332613NA1 site📍 New York Weill Medical College of Cornell University · Tests: TRE plus SOC, SOC, TRE Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease NCT05439226NA3 sites📍 Yichang📍 Changsha📍 Changsha State Key Laboratory of Subhealth Intervention Technology · Tests: CMNT diet Lifestyle Modification in the Treatment of NAFLD. NCT05816915NA1 site📍 Prague General University Hospital, Prague · Tests: Cognitive behavioral therapy Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) NCT04634643n/a1 site📍 New Haven Yale University · Tests: Usual diet and physical activity A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH NCT06920043Phase 230 sites📍 Chandler📍 Mesa📍 Tucson GlaxoSmithKline · Tests: Efimosfermin, Placebo Cardiac Dysfunction in Patients with Fatty Liver Disease NCT06386094n/a1 site📍 Chandigarh Post Graduate Institute of Medical Education and Research, … · Tests: Echocardiographic assessment Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet. NCT05477212NA1 site📍 Castellana Grotte Azienda Ospedaliera Specializzata in Gastroenterologia Save… · Tests: Ketogenic Diet Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With Obesity NCT07662356n/a1 site📍 Hong Kong Chinese University of Hong Kong · Tests: Case Group A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH NCT07221227Phase 391 sites📍 Chandler📍 Tucson📍 Little Rock GlaxoSmithKline · Tests: Efimosfermin alfa, Efimosfermin alfa, Placebo The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) NCT07093346NA3 sites📍 Nottingham📍 Nottingham📍 Nottingham University of Nottingham · Tests: Pectin, Cocoa Powder, Magnetic Resonance Imaging with Contrast COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study NCT06704516Phase 11 site📍 Oxford University of Oxford · Tests: Menopausal hormone therapy The European NAFLD Registry NCT04442334n/a37 sites📍 Antwerp📍 Helsinki📍 Angers Newcastle University Identification of Liver Fibrosis Biomarkers NCT06819917n/a2 sites📍 Copenhagen📍 Mainz Roche Diagnostics GmbH · Tests: Identification of liver fibrosis biomarkers Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo) NCT07330830n/a3 sites📍 Cayenne📍 Pointe-à-Pitre📍 Saint-Denis Centre Hospitalier Universitaire de la Guadeloupe Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis NCT07270601NA1 site📍 Seattle ContextVision AB · Tests: Verasonics NXT Data Acquisition System, Philips EPIQ Elite, EchoSense FibroScan, Philips 3T Ingenia Elition The COherence of Scatter Identification and Exclusion Algorithm Study NCT06975579n/a1 site📍 London Institute of Cancer Research, United Kingdom · Tests: Ultrasound image processing Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes NCT06989723Phase 41 site📍 Seongnam-si Seoul National University Bundang Hospital · Tests: Pioglitazone 15 MG [Actos], Empagliflozin 10 MG [Jardiance], Empagliflozin 10 MG [Jardiance] + Pioglitazone 15 MG [Acto… Prevention of NAFLD and CVD Through Lifestyle Intervention NCT05618626NA1 site📍 Molina Pontificia Universidad Catolica de Chile · Tests: Physical exercise and dietary intervention for NAFLD Comparison of ALD, NASH, and Healthy Control Patients NCT03224949n/a1 site📍 Cleveland The Cleveland Clinic · Tests: Blood draw A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition NCT05519475Phase 271 sites📍 Flagstaff📍 Peoria📍 Tucson Regeneron Pharmaceuticals · Tests: ALN-HSD, Placebo Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease NCT05309863n/a3 sites📍 Ghent📍 Ghent📍 De Haan University Hospital, Ghent · Tests: Lifestyle management Reversal of Lipid-Induced Insulin Resistance NCT02193295NA2 sites📍 New Haven📍 New Haven Yale University · Tests: Caloric Restriction
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy